XTL Biopharmaceuticals Ltd.

Regulatory Filings • Aug 16, 2007

_________

C007��� �� �� ������������� ��"�2PublicX T L BIOPHARMACEUTICALS LTD4313Corporation no: 520039470Stock Exchange/Market: ��� �� ��1996428Hasapir 3 , Nes Ziona 76100 , ,Tel: 08-9304444 , Fax: 08-9304445E.mail address: rcohen@xtlbio.comDate of transmission: 16/08/2007              Time of broadcast: 16:51 16:49:21

Reference: 2007-02-360901

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Annual General Meeting / Special MeetingRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000Only for corporation incorporated in Israel

On 25/09/2007 at 16:00 the corporation will hold it's annual general meetingat Building no.3, Kiryat Weizmann, Rehovot, P.O Box 370, Israel 76100

According to section 182 B of the Companies law, 5759-1999, only shareholders of record at the close of business 13/08/2007 will be entitled to notice of, and to vote at, the Meeting.

Attached hereto is the report CIRCULARFINAL_isa.pdf

Attached hereto is the proxy statement FINALProxyandFOI_isa.pdf

On 25/09/2007 at 16:30 the corporation will hold it's special meeting at Building no.3, Kiryat Weizmann, Rehovot, P.O Box 370, Israel 76100. According to section 182B of the Companies law, 5759-1999, only shareholders of record at the close of business 13/08/2007 will be entitled to nitice of, and to vote at, the meeting. The Circular and Proxy Attached, refers to the special meeting as well.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2007-02-359122
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 28/06/2007
- - -
Name of the Signatory: : Kantor Ronen , , Position of Signatory in the reporting corporation: Legal Consultant & Corporate Secretary
Abba Hillel Silver Telephone: 03-6133371 , Facsimile: 03-6133372 , E-mail: rkantor@kantor-law.com